The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis

Author(s): Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, et al.

Abstract

Background: Overweight and obese persons are at risk of a number of medical conditions which can lead to further morbidity and mortality. The primary objective of this study is to provide an estimate of the incidence of each co-morbidity related to obesity and overweight using a meta-analysis.

Methods: A literature search for the twenty co-morbidities identified in a preliminary search was conducted in Medline and Embase (Jan 2007). Studies meeting the inclusion criteria (prospective cohort studies of sufficient size reporting risk estimate based on the incidence of disease) were extracted. Study-specific unadjusted relative risks (RRs) on the log scale comparing overweight with normal and obese with normal were weighted by the inverse of their corresponding variances to obtain a pooled RR with 95% confidence intervals (CI).

Results: A total of 89 relevant studies were identified. The review found evidence for 18 co-morbidities which met the inclusion criteria. The meta-analysis determined statistically significant associations for overweight with the incidence of type II diabetes, all cancers except esophageal (female), pancreatic and prostate cancer, all cardiovascular diseases (except congestive heart failure), asthma, gallbladder disease, osteoarthritis and chronic back pain. We noted the strongest association between overweight defined by body mass index (BMI) and the incidence of type II diabetes in females (RR = 3.92 (95% CI: 3.10-4.97)). Statistically significant associations with obesity were found with the incidence of type II diabetes, all cancers except esophageal and prostate cancer, all cardiovascular diseases, asthma, gallbladder disease, osteoarthritis and chronic back pain. Obesity defined by BMI was also most strongly associated with the incidence of type II diabetes in females (12.41 (9.03-17.06)).

Conclusion: Both overweight and obesity are associated with the incidence of multiple co-morbidities including type II diabetes, cancer and cardiovascular diseases. Maintenance of a healthy weight could be important in the prevention of the large disease burden in the future. Further studies are needed to explore the biological mechanisms that link overweight and obesity with these co-morbidities.

Similar Articles

Incidence of endometrial hyperplasia

Author(s): Reed SD, Newton KM, Clinton WL, Epplein M, Garcia R, et al.

Seromucinous Tumors of the Ovary

Author(s): Kurman RJ, Shih IeM

Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia

Author(s): Lacey JV Jr, Sherman ME, Rush BB, Ronnett BM, Ioffe OB, et al.

Modifiable risk factors for cancer

Author(s): Stein CJ, Colditz GA

Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy

Author(s): Reed SD, Newton KM, Garcia RL, Allison KH, Voigt LF, et al.

Risk factors for endometrial hyperplasia: results from a case-control study

Author(s): Ricci E, Moroni S, Parazzini F, Surace M, Benzi G, et al.

High rate of endometrial hyperplasia in renal transplanted women

Author(s): Bobrowska K, Kamiński P, Cyganek A, Pietrzak B, Jabiry-Zieniewicz Z, et al.

Clinical parameters linked with malignancy in endometrial polyps

Author(s): Gregoriou O, Konidaris S, Vrachnis N, Bakalianou K, Salakos N, et al.

Measuring inconsistency in meta-analyses

Author(s): Higgins JP, Thompson SG, Deeks JJ, Altman DG

Quantifying heterogeneity in a meta-analysis

Author(s): Higgins JP, Thompson SG

Bias in meta-analysis detected by a simple, graphical test

Author(s): Egger M, Davey Smith G, Schneider M, Minder C

Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women

Author(s): Viola AS, Gouveia D, Andrade L, Aldrighi JM, Viola CF, et al.

Risk factors for adenomatous endometrial hyperplasia: a case-control study

Author(s): Kreiger N, Marrett LD, Clarke EA, Hilditch S, Woolever CA

Endometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapy

Author(s): Epplein M, Reed SD, Voigt LF, Newton KM, Holt VL, et al.

Characteristics of women with a family history of ovarian cancer

Author(s): Cramer DW, Barbieri RL, Muto MG, Kelly A, Brucks JP, et al.

Cigarette smoking, relative weight, and menopause

Author(s): Willett W, Stampfer MJ, Bain C, Lipnick R, Speizer FE, et al.

Tobacco smoking and cancer: a meta-analysis

Author(s): Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, et al.

Smoking and colorectal cancer: a meta-analysis

Author(s): Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, et al.

An aggregated analysis of hormonal factors and endometrial cancer risk by parity

Author(s): Schonfeld SJ, Hartge P, Pfeiffer RM, Freedman DM, Greenlee RT, et al.

IUD use and the risk of endometrial cancer

Author(s): Benshushan A, Paltiel O, Rojansky N, Brzezinski A, Laufer N

Risk factors among young women with endometrial cancer: a Danish case-control study

Author(s): Parslov M, Lidegaard O, Klintorp S, Pedersen B, Jønsson L, et al.

A case-control study of cancer of the endometrium

Author(s): Kelsey JL, LiVolsi VA, Holford TR, Fischer DB, Mostow ED, et al.

Epidemiology of endometrial cancer

Author(s): Elwood JM, Cole P, Rothman KJ, Kaplan SD

Family history and the risk of endometrial cancer

Author(s): Parazzini F, La Vecchia C, Moroni S, Chatenoud L, Ricci E